ResMed Inc. Financial Ratios — RMD.AX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	22.72	20.55	20.86	20.56	18.78	17.04	15.29	13.29	16.62	23.59	16.05	23.29	22.82	22.08	25.3
Return on Assets (%)	12.29	12.12	14.13	15.1	15.54	12.96	10.18	9.66	11.28	14.3	10.19	15.87	15.15	14.99	18.62
Return on Capital (%)	20.57	18.27	17.86	17.69	16.41	12.88	10.86	10.89	13.48	16.73	12.17	18.98	18.06	18.08	21.89
Return on Invested Capital (%)	12.22	12.13	14.74	16.38	16.63	14.51	12.48	12.16	16.76	18.86	12.5	19.58	18.57	19.21	21.99
Gross Margin (%)	59.63	59.97	62.11	63.65	60.24	58	56.72	57.04	57.32	58.09	57.53	56.57	55.78	56.67	59.36
EBITDA Margin (%)	27.15	27.79	28.6	31.18	28.73	28.43	27.53	29.07	30.18	33.49	34.53	33.43	31.96	34.16	37.37
Operating Margin (%)	21.47	21.51	23.43	26.46	24.38	23.7	22.1	23.94	24.4	27.36	28.54	28.01	27.28	29.54	32.79
Incremental Operating Margin (%)	15.61	21.92	41.4	139.67	-1.76	16.66	9.15	37.86	28.43	49.39	43.07	23.55	23.24	50.21	65.78
Pretax Margin (%)	24.43	24.26	25.43	27.72	25.96	23.91	20.26	22.28	19.91	24.79	27.64	26.84	26.09	27	32.6
Profit Margin (%)	18.26	18.62	20.28	22.2	21.02	19.17	16.56	13.49	15.52	21.02	14.84	21.78	21.25	21.79	27.22
Net Income to Common Margin (%)	18.26	18.62	20.28	22.2	21.02	19.17	16.56	13.49	15.52	21.02	14.84	21.78	21.25	21.79	27.22
Effective Tax Rate (%)	25.26	23.23	20.25	19.9	19.05	19.83	18.26	39.46	22.02	15.2	46.3	18.85	18.53	19.28	16.5
Dvd Payout Ratio (%)	- -	- -	31.65	40.99	44.56	47.71	54.44	63.21	52.33	36.21	47.78	31.48	28.78	27.65	22.19
Sustainable Growth Rate (%)	22.72	20.55	14.26	12.13	10.41	8.91	6.97	4.89	7.92	15.05	8.38	15.96	16.25	15.98	19.68

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	100	251	301	301	301	1,173	1,079	281	1,271	1,299	794	918	1,580	874	852
ST Debt	- -	- -	300	- -	- -	299	- -	11	12	33	36	32	32	35	40
LT Debt	100	251	1	301	301	873	1,079	270	1,259	1,266	758	886	1,548	839	811
Total Debt/EBITDA	0.3	0.66	0.69	0.62	0.62	2.24	1.9	0.41	1.62	1.31	0.72	0.77	1.17	0.55	0.44
Net Debt/EBITDA	-1.88	-1.47	-1.33	-1.25	-0.86	0.84	0.45	0.14	1.43	0.72	0.33	0.42	0.9	0.29	-0.28
Total Debt/EBIT	0.38	0.85	0.85	0.73	0.73	2.69	2.36	0.5	2	1.61	0.87	0.92	1.37	0.63	0.5
Net Debt/EBIT	-2.38	-1.9	-1.62	-1.47	-1.02	1.01	0.56	0.17	1.77	0.88	0.39	0.5	1.05	0.34	-0.32
EBITDA to Interest Expense	192	79.45	67.81	79.11	83.47	46.65	20.15	23.99	21.76	24.53	46.02	53.6	28.48	35.01	- -
EBITDA-CapEx/Interest Expense	150.46	66.69	56.57	65.87	71.02	40.59	17.62	21.47	19.62	21.91	41.15	46.61	25.66	32.5	- -
EBIT to Interest Expense	151.83	61.51	55.55	67.13	70.83	38.9	16.18	19.76	17.59	20.04	38.03	44.92	24.31	30.28	- -
Interest Expense	2	5	6	6	6	11	28	28	36	40	24	22	47	46	- -
Common Equity/Total Assets	53.77	63.96	71.34	75.43	90.6	66.35	66.8	79.4	59.33	61.77	65.15	70.93	63	72.64	74.41
Long-Term Debt/Equity (%)	5.78	15.6	0.05	17.11	18.94	51.53	55.02	13.11	60.75	50.7	26.27	26.36	37.48	17.24	13.6
Long-Term Debt/Capital (%)	8.25	15.5	0.04	14.45	13.2	26.2	31.77	9.95	33.95	30.63	19.57	19.55	26.54	14.3	11.7
Long-Term Debt/Total Assets (%)	4.83	11.73	0.03	12.74	13.78	26.82	31.1	8.81	30.65	27.6	16.03	17.38	22.93	12.2	9.93
Total Debt/Equity (%)	5.79	15.6	18.68	17.11	18.94	69.2	55.02	13.67	61.33	52.03	27.51	27.3	38.26	17.97	14.27
Total Debt/Capital (%)	8.26	15.5	16.02	14.45	13.2	35.18	31.77	10.37	34.27	31.44	20.49	20.25	27.08	14.9	12.28
Total Debt/Total Assets (%)	4.84	11.73	13.61	12.74	13.78	36.01	31.1	9.19	30.94	28.32	16.79	18.01	23.4	12.72	10.42
Net Debt to Equity	-36.7	-34.75	-35.72	-34.41	-26.25	26.04	13.09	4.5	54.23	28.55	12.48	14.92	29.38	9.64	-9.07
Net Debt/Capital (%)	-133.04	-69.1	-57.41	-51.44	-26.71	16.96	9.97	3.67	31.56	19.43	10.06	11.78	21.64	8.33	-9.45
EBITDA	338	380	433	485	482	523	569	680	787	990	1,104	1,196	1,350	1,600	1,923
EBITDA-CapEx	264	319	361	404	410	455	497	609	709	884	987	1,040	1,216	1,485	1,823
Operating Income (Loss)	267	294	355	411	409	436	457	560	636	809	912	1,002	1,152	1,384	1,687

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	3.52	3.2	1.53	3.36	2.69	1.15	2.28	0.37	0.26	0.77	0.32	0.4	0.3	0.26	1.19
Current Ratio	6.19	5.38	2.52	5.77	5.28	2.23	4.57	2.08	2.06	2.53	1.73	2.8	3.12	2.59	3.44
Quick Ratio	4.88	4.33	2.1	4.69	4.05	1.75	3.53	1.32	1.22	1.56	1	1.23	1.23	1.22	2.16
CFO/Avg Current Liab	1.09	1.66	0.97	0.93	1.43	1.21	0.83	1.16	0.86	1.38	0.97	0.44	0.96	1.68	1.82
Common Equity/Total Assets	53.77	63.96	71.34	75.43	90.6	66.35	66.8	79.4	59.33	61.77	65.15	70.93	63	72.64	74.41
Long-Term Debt/Equity (%)	5.78	15.6	0.05	17.11	18.94	51.53	55.02	13.11	60.75	50.7	26.27	26.36	37.48	17.24	13.6
Long-Term Debt/Capital (%)	8.25	15.5	0.04	14.45	13.2	26.2	31.77	9.95	33.95	30.63	19.57	19.55	26.54	14.3	11.7
Long-Term Debt/Total Assets (%)	4.83	11.73	0.03	12.74	13.78	26.82	31.1	8.81	30.65	27.6	16.03	17.38	22.93	12.2	9.93
Total Debt/Equity (%)	5.79	15.6	18.68	17.11	18.94	69.2	55.02	13.67	61.33	52.03	27.51	27.3	38.26	17.97	14.27
Total Debt/Capital (%)	8.26	15.5	16.02	14.45	13.2	35.18	31.77	10.37	34.27	31.44	20.49	20.25	27.08	14.9	12.28
Total Debt/Total Assets (%)	4.84	11.73	13.61	12.74	13.78	36.01	31.1	9.19	30.94	28.32	16.79	18.01	23.4	12.72	10.42
CFO/Total Liabilities	83.74	72.26	67.11	64.92	64.46	35.08	27.45	50.25	22.55	38.38	39.99	20.24	26.44	69.77	79.38
CFO/CapEx	3.88	6.27	5.61	4.82	5.33	8.08	5.79	7.07	5.94	7.57	6.31	2.25	5.17	12.2	17.4
Altman's Z-Score	9.98	7.55	8.92	9.92	11.05	6.89	7.98	13.11	10.06	12.38	16.02	15.24	11.86	13.31	15.09

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	4.96	4.91	5.04	4.59	4.65	4.94	4.96	5.01	5.15	5.9	5.87	6.01	6.59	6.08	5.79
Days Sales Outstanding	73.59	74.35	72.48	79.57	78.5	73.91	73.52	72.85	70.87	61.91	62.17	60.71	55.35	60.07	63.01
Inventory Turnover	2.6	2.92	3.58	3.63	3.24	3.28	3.63	3.74	3.6	3.23	3.11	2.59	2.14	2.23	2.39
Days Inventory Outstanding	140.53	124.98	101.84	100.51	112.72	111.39	100.54	97.49	101.44	112.89	117.47	141.05	170.24	163.64	152.71
Accounts Payable Turnover	9.17	9.46	9.43	8.01	9	8.63	10.13	10.84	11.45	10.39	10.21	12.38	13.69	9.55	8.52
Accounts Payable Turnover Days	39.8	38.58	38.72	45.59	40.58	42.27	36.05	33.66	31.88	35.13	35.75	29.47	26.67	38.24	42.86
Cash Conversion Cycle	174.32	160.75	135.61	134.48	150.64	143.02	138.02	136.68	140.43	139.67	143.89	172.29	198.93	185.48	172.86
Inventory to Cash Days	-66.94	-50.63	-29.36	-20.94	-34.22	-37.48	-27.02	-24.64	-30.57	-50.98	-55.31	-80.35	-114.89	-103.57	-89.7
Inventories	201	174	146	165	247	224	268	269	350	417	457	744	998	822	928
Raw Materials	74	66	47	54	74	67	76	75	81	128	155	355	459	356	367
Work In Process	4	2	2	3	3	4	4	2	2	3	5	3	4	3	3
Finished Goods	123	107	97	108	170	153	188	191	267	286	297	386	535	464	558
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	4,054	3,974	5,771	6,524	7,152	8,004	10,252	14,182	16,822	26,573	34,756	30,272	31,568	27,585	37,983
- Cash & Cash Equivalents	735	810	876	906	717	731	822	189	147	463	295	274	228	238	1,209
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	100	251	301	301	301	1,173	1,079	281	1,271	1,299	794	918	1,580	874	852
Enterprise Value	3,419	3,416	5,195	5,919	6,736	8,445	10,508	14,275	17,946	27,409	35,255	30,915	32,920	28,221	37,625
Total Capital	1,213	1,618	1,878	2,082	2,277	3,334	3,395	2,714	3,708	4,133	3,874	4,532	5,834	5,866	6,934
Total Debt/Capital (%)	8.26	15.5	16.02	14.45	13.2	35.18	31.77	10.37	34.27	31.44	20.49	20.25	27.08	14.9	12.28
Total Debt / EV	0.03	0.07	0.06	0.05	0.04	0.14	0.1	0.02	0.07	0.05	0.02	0.03	0.05	0.03	0.02
EV/Sales	2.75	2.5	3.43	3.81	4.01	4.59	5.08	6.1	6.88	9.27	11.03	8.64	7.8	6.02	7.31
EV/EBITDA	10.13	8.98	12	12.21	13.97	16.16	18.47	20.99	22.81	27.67	31.94	25.85	24.39	17.63	19.56
EV/EBIT	12.81	11.6	14.64	14.39	16.46	19.38	23.01	25.48	28.22	33.88	38.64	30.85	28.58	20.39	22.3
EV/Cash Flow to Firm	12.02	8.83	12.74	14.94	17.37	15.16	24.04	27.34	36.83	32.77	47.03	83.72	44.98	19.62	21.48
EV/Free Cash Flow to Firm	9.56	7.63	10.83	12.4	14.65	13.52	20.66	24.05	31.79	29.08	40.69	58.85	38.02	18.17	20.31
Diluted Market Cap	4,180	4,067	5,910	6,657	7,265	8,085	10,331	14,303	16,984	26,815	35,029	30,474	31,716	27,684	38,144
Diluted Enterprise Value	3,544	3,509	5,335	6,052	6,849	8,526	10,587	14,396	18,107	27,651	35,527	31,118	33,068	28,320	37,787
EV per Share	2.24	2.34	3.63	4.18	4.8	6.02	7.43	10	12.54	18.99	24.26	21.17	22.43	19.19	25.64
TTM Sales	1,243	1,369	1,514	1,555	1,679	1,839	2,067	2,340	2,607	2,957	3,197	3,578	4,223	4,685	5,146
TTM EBITDA	338	380	433	485	482	523	569	680	787	990	1,104	1,196	1,350	1,600	1,923
TTM Operating Income	267	294	355	411	409	436	457	560	636	809	912	1,002	1,152	1,384	1,687
TTM Cash Flow to Firm	285	387	408	396	388	557	437	522	487	836	750	369	732	1,438	1,752
TTM Free Cash Flow to Firm	358	448	480	477	460	625	509	594	565	942	866	525	866	1,553	1,852

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	11.73	9.16	12.45	14.09	15.96	13.13	21.28	24.81	31.66	29.53	41.04	60.08	38.34	18.26	20.59
EV/EBIT	12.81	11.6	14.64	14.39	16.46	19.38	23.01	25.48	28.22	33.88	38.64	30.85	28.58	20.39	22.3
Enterprise Value	3,419	3,416	5,195	5,919	6,736	8,445	10,508	14,275	17,946	27,409	35,255	30,915	32,920	28,221	37,625
Low Price	2.92	2.34	3.05	4.25	4.59	4.89	5.46	7.12	9.05	10.51	16.62	18.93	20.38	13.31	18.62
EV/Sales	2.75	2.5	3.43	3.81	4.01	4.59	5.08	6.1	6.88	9.27	11.03	8.64	7.8	6.02	7.31
EV/EBITDA	10.13	8.98	12	12.21	13.97	16.16	18.47	20.99	22.81	27.67	31.94	25.85	24.39	17.63	19.56
Price/Earnings	17.86	15.6	18.79	18.9	20.27	22.71	29.95	44.94	41.58	42.74	73.25	38.84	35.17	27.02	27.12
Price/Earnings Average	18.85	14.67	17.11	17.69	20.75	20.64	25.84	37.85	36.45	33.36	59.06	45.2	35.56	25.76	24.42
Price/Earnings High	24.34	19.92	23.86	23.48	30.03	25.44	32.65	48.97	43.59	44.38	76.11	56.3	40.28	32.65	27.41
Price/Earnings Low	19.63	13.39	14.18	17.43	18.26	19.44	22.53	32.22	32.01	24.4	50.9	35.48	33.32	19.16	19.5
Price/Book Value	3.64	2.91	3.66	3.66	3.62	3.7	4.42	5.83	6.9	9.38	11.28	8.38	7.42	5.53	6.24
Price/Book Value Average	3.85	2.74	3.33	3.43	3.7	3.37	3.82	4.91	6.05	7.32	9.1	9.75	7.5	5.27	5.62
Price/Book Value High	4.97	3.71	4.65	4.55	5.36	4.15	4.82	6.35	7.24	9.74	11.73	12.14	8.5	6.68	6.31
Price/Book Value Low	4.01	2.5	2.76	3.38	3.26	3.17	3.33	4.18	5.32	5.35	7.84	7.65	7.03	3.92	4.49
Price/Tangible Book Value	2.8	3.07	4.49	4.58	5.61	23.84	16.18	18.3	-54.94	167.62	61.49	28.07	39.1	17.96	15.46
Price/Tangible Book Value Average	2.96	2.88	4.09	4.29	5.74	21.66	13.96	15.42	-48.17	130.83	49.58	32.67	39.53	17.12	13.92
Price/Tangible Book Value High	3.82	3.92	5.7	5.69	8.31	26.7	17.64	19.95	-57.6	174.03	63.9	40.69	44.79	21.7	15.63
Price/Tangible Book Value Low	3.08	2.63	3.39	4.23	5.05	20.4	12.17	13.12	-42.3	95.69	42.73	25.64	37.05	12.74	11.12
Price/Sales	3.26	2.9	3.81	4.2	4.26	4.35	4.96	6.06	6.45	8.99	10.87	8.46	7.48	5.89	7.38
Price/Sales Average	3.44	2.73	3.47	3.93	4.36	3.96	4.28	5.1	5.66	7.01	8.77	9.85	7.56	5.61	6.65
Price/Sales High	4.44	3.71	4.84	5.21	6.31	4.88	5.41	6.6	6.77	9.33	11.3	12.26	8.56	7.11	7.46
Price/Sales Low	3.59	2.49	2.87	3.87	3.84	3.73	3.73	4.34	4.97	5.13	7.55	7.73	7.08	4.18	5.31
Price/Cash Flow	14.32	10.37	14.33	16.67	18.67	14.61	24.76	28.08	36.65	33.12	47.18	86.21	45.53	19.69	21.68
Price/Cash Flow Average	15.11	9.76	13.04	15.61	19.11	13.28	21.36	23.65	32.13	25.85	38.04	100.32	46.03	18.77	19.52
Price/Cash Flow High	19.51	13.25	18.19	20.72	27.66	16.36	26.99	30.6	38.42	34.39	49.02	124.96	52.15	23.79	21.92
Price/Cash Flow Low	15.74	8.9	10.81	15.38	16.82	12.5	18.62	20.13	28.22	18.91	32.78	78.74	43.14	13.96	15.6
Price/Free Cash Flow Average	12.38	8.62	11.34	13.19	16.34	11.93	18.36	20.9	27.76	23.05	33.09	69.92	38.76	17.41	18.54
Price/Free Cash Flow High	15.99	11.69	15.81	17.51	23.66	14.71	23.19	27.04	33.19	30.65	42.65	87.09	43.91	22.06	20.82
Price/Free Cash Flow Low	12.9	7.86	9.4	13	14.39	11.24	16.01	17.79	24.38	16.86	28.52	54.88	36.32	12.95	14.81
EV/Sales Average	2.93	2.32	3.09	3.54	4.11	4.2	4.4	5.14	6.09	7.3	8.92	10.02	7.88	5.75	6.58
EV/Sales High	3.93	3.3	4.46	4.82	6.06	5.12	5.53	6.64	7.2	9.61	11.45	12.44	8.88	7.25	7.39
EV/Sales Low	3.07	2.08	2.49	3.48	3.59	3.97	3.86	4.38	5.4	5.41	7.71	7.91	7.4	4.31	5.24
EV/EBITDA Average	10.8	8.37	10.8	11.35	14.32	14.76	16	17.7	20.17	21.79	25.84	29.99	24.65	16.83	17.6
EV/EBITDA High	14.48	11.88	15.59	15.47	21.11	18	20.09	22.86	23.84	28.7	33.17	37.23	27.79	21.22	19.78
EV/EBITDA Low	11.32	7.5	8.72	11.17	12.5	13.95	14.01	15.08	17.89	16.16	22.33	23.66	23.16	12.62	14.02
EV/EBIT Average	13.65	10.81	13.19	13.37	16.87	17.7	19.93	21.49	24.96	26.67	31.26	35.79	28.88	19.46	20.06
EV/EBIT High	18.31	15.34	19.03	18.23	24.88	21.58	25.03	27.75	29.5	35.13	40.13	44.43	32.56	24.54	22.54
EV/EBIT Low	14.32	9.69	10.65	13.16	14.73	16.73	17.45	18.31	22.13	19.78	27.02	28.23	27.14	14.59	15.98
Last Price	2.66	2.72	4.04	4.61	5.09	5.71	7.25	9.93	11.75	18.41	23.92	20.72	21.51	18.76	25.89
High Price	3.62	3.48	5.13	5.73	7.55	6.39	7.91	10.83	12.32	19.11	24.85	30.04	24.64	22.67	26.17
Enterprise Value Average	3,644	3,181	4,679	5,502	6,905	7,716	9,102	12,038	15,873	21,578	28,522	35,871	33,265	26,936	33,842
Enterprise Value High	4,889	4,518	6,753	7,500	10,182	9,407	11,431	15,547	18,760	28,425	36,615	44,522	37,510	33,965	38,033
Enterprise Value Low	3,822	2,853	3,778	5,414	6,029	7,293	7,968	10,260	14,077	16,006	24,649	28,294	31,262	20,201	26,962

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	152	142	142	140	140	141	142	143	144	145	146	146	147	147	146
Diluted Weighted Avg Shares	1,572	1,493	1,464	1,444	1,427	1,417	1,425	1,440	1,445	1,457	1,465	1,470	1,475	1,476	1,473
Basic Weighted Avg Shares	1,525	1,459	1,430	1,415	1,405	1,402	1,414	1,428	1,431	1,443	1,453	1,461	1,468	1,470	1,467
Revenue per Share	0.82	0.94	1.06	1.1	1.2	1.31	1.46	1.64	1.82	2.05	2.2	2.45	2.88	3.19	3.51
EBITDA per Share	0.22	0.26	0.3	0.34	0.34	0.37	0.4	0.48	0.55	0.69	0.76	0.82	0.92	1.09	1.31
Operating Income per Share	0.18	0.2	0.25	0.29	0.29	0.31	0.32	0.39	0.44	0.56	0.63	0.69	0.78	0.94	1.15
Basic EPS, GAAP	0.15	0.17	0.21	0.24	0.25	0.25	0.24	0.22	0.28	0.43	0.33	0.53	0.61	0.69	0.95
Basic EPS from Cont Ops	0.15	0.17	0.21	0.24	0.25	0.25	0.24	0.22	0.28	0.43	0.33	0.53	0.61	0.69	0.95
Diluted EPS, GAAP	0.14	0.17	0.21	0.24	0.25	0.25	0.24	0.22	0.28	0.43	0.32	0.53	0.61	0.69	0.95
Diluted EPS from Cont Ops	0.14	0.17	0.21	0.24	0.25	0.25	0.24	0.22	0.28	0.43	0.32	0.53	0.61	0.69	0.95
Dividend per Share	- -	- -	0.07	0.1	0.11	0.12	0.13	0.14	0.15	0.16	0.16	0.17	0.18	0.19	0.21
Cash Flow per Share	0.19	0.26	0.28	0.28	0.27	0.39	0.29	0.35	0.32	0.56	0.51	0.24	0.47	0.95	1.19
Free Cash Flow per Basic Share	0.14	0.22	0.23	0.22	0.22	0.34	0.24	0.3	0.27	0.48	0.43	0.13	0.38	0.87	1.13
Cash & Equivalents per Share	0.48	0.55	0.61	0.64	0.51	0.52	0.58	0.13	0.1	0.32	0.2	0.19	0.16	0.16	0.82
Book Value per Share	0.73	0.94	1.1	1.26	1.41	1.54	1.64	1.7	1.7	1.96	2.12	2.47	2.9	3.4	4.15
Tangible Book Value per Share	0.95	0.89	0.9	1.01	0.91	0.24	0.45	0.54	-0.21	0.11	0.39	0.74	0.55	1.04	1.67

ResMed Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)